[{"address1": "Gooimeer 2-35", "city": "Naarden", "zip": "1411 DC", "country": "Netherlands", "phone": "31 35 206 2971", "website": "https://www.newamsterdampharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with metabolic disease. It is developing obicetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in various clinical trials as a monotherapy and a combination therapy with ezetimibe for lowering LDL-C for cardiovascular diseases. The company also develops Obicetrapib which is in Phase 2a clinical trial for Alzheimer's disease. NewAmsterdam Pharma Company N.V. is headquartered in Naarden, the Netherlands.", "fullTimeEmployees": 40, "maxAge": 86400, "priceHint": 2, "previousClose": 7.4, "open": 7.5, "dayLow": 7.4, "dayHigh": 7.4, "regularMarketPreviousClose": 7.4, "regularMarketOpen": 7.5, "regularMarketDayLow": 7.4, "regularMarketDayHigh": 7.4, "beta": 0.011, "volume": 7, "regularMarketVolume": 7, "averageVolume": 5058, "averageVolume10days": 6330, "averageDailyVolume10Day": 6330, "fiftyTwoWeekLow": 0.99, "fiftyTwoWeekHigh": 14.67, "fiftyDayAverage": 9.28184, "twoHundredDayAverage": 6.30124, "currency": "USD", "floatShares": 29154198, "bookValue": 10.838, "priceToBook": 0.68278277, "netIncomeToCommon": -228686000, "52WeekChange": 2.681592, "SandP52WeekChange": 0.26238096, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "NAMSW", "underlyingSymbol": "NAMSW", "shortName": "NewAmsterdam Pharma Company N.V", "longName": "NewAmsterdam Pharma Company N.V.", "firstTradeDateEpochUtc": 1612967400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "072ede56-783e-317d-b7d9-5dc797a27eef", "messageBoardId": "finmb_685404834", "gmtOffSetMilliseconds": -14400000, "currentPrice": 7.4, "recommendationKey": "none", "totalCash": 481147008, "totalCashPerShare": 5.347, "ebitda": -198540992, "totalDebt": 43000, "quickRatio": 8.125, "currentRatio": 8.168, "totalRevenue": 6862000, "debtToEquity": 0.01, "revenuePerShare": 0.082, "returnOnAssets": -0.24816999, "returnOnEquity": -0.54328, "freeCashflow": -82202408, "operatingCashflow": -163956992, "revenueGrowth": -0.838, "grossMargins": 1.0, "operatingMargins": -39.601707, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-06-24"}]